These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32474746)

  • 1. Unleash the Association of Mitochondrial Uncoupling Protein (UCP2) Promoter Variant (G-866A; rs659366) with Obesity: Stepping from a Case-Control Study to a Meta-analysis.
    Abd El Daim HA; Elsaid AM; Mousa AA; El-Eshmawy MM; Lashin LS; Toraih EA; Elshazli RM
    Biochem Genet; 2020 Oct; 58(5):738-770. PubMed ID: 32474746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.
    Andersen G; Dalgaard LT; Justesen JM; Anthonsen S; Nielsen T; Thørner LW; Witte D; Jørgensen T; Clausen JO; Lauritzen T; Holmkvist J; Hansen T; Pedersen O
    Int J Obes (Lond); 2013 Feb; 37(2):175-81. PubMed ID: 22349573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
    D'Adamo M; Perego L; Cardellini M; Marini MA; Frontoni S; Andreozzi F; Sciacqua A; Lauro D; Sbraccia P; Federici M; Paganelli M; Pontiroli AE; Lauro R; Perticone F; Folli F; Sesti G
    Diabetes; 2004 Jul; 53(7):1905-10. PubMed ID: 15220218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of uncoupling protein-2 -866G/A and Ala55Val polymorphisms with susceptibility to type 2 diabetes mellitus: A meta-analysis of case-control studies.
    Xu L; Chen S; Zhan L
    Medicine (Baltimore); 2021 Feb; 100(6):e24464. PubMed ID: 33578539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients.
    Pehlivan S; Aytac HM; Kurnaz S; Pehlivan M; Cetinay Aydin P
    J Addict Dis; 2020; 38(4):495-505. PubMed ID: 32662357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of UCP1 and UCP2 variants with diabetic retinopathy susceptibility in type-2 diabetes mellitus patients: a meta-analysis.
    Liu X; Jiang Z; Zhang G; Ng TK; Wu Z
    BMC Ophthalmol; 2021 Feb; 21(1):81. PubMed ID: 33579234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between obesity and insulin resistance with UCP2-UCP3 gene variants in Spanish children and adolescents.
    Ochoa MC; Santos JL; Azcona C; Moreno-Aliaga MJ; Martínez-González MA; Martínez JA; Marti A;
    Mol Genet Metab; 2007 Dec; 92(4):351-8. PubMed ID: 17870627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study.
    Heidari J; Akrami SM; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Arch Iran Med; 2010 Sep; 13(5):384-90. PubMed ID: 20804304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.
    Beitelshees AL; Finck BN; Leone TC; Cresci S; Wu J; Province MA; Fabbrini E; Kirk E; Zineh I; Klein S; Spertus JA; Kelly DP
    Pharmacogenet Genomics; 2010 Apr; 20(4):231-8. PubMed ID: 20145583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The A allele of the UCP2 -866G/A polymorphism changes UCP2 promoter activity in HUVECs treated with high glucose.
    Crispim D; Rodrigues M; da Silva LPA; Bouças AP; Canani LH; Carlessi R; de Souza BM
    Mol Biol Rep; 2019 Oct; 46(5):4735-4741. PubMed ID: 31218541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UCP2 and CFH Gene Variants with Genetic Susceptibility to Schizophrenia in Turkish Population.
    Nursal AF; Aydin PC; Pehlivan M; Sever U; Pehlivan S
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2084-2089. PubMed ID: 33191890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The -866G/A polymorphism in the promoter of the UCP2 gene is associated with risk for type 2 diabetes and with decreased insulin levels.
    Gomathi P; Samarth AP; Raj NBAJ; Sasikumar S; Murugan PS; Nallaperumal S; Selvam GS
    Gene; 2019 Jun; 701():125-130. PubMed ID: 30910560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study of the association of polymorphism rs659366 gene UCP2 c obesity and type 2 diabetes among residents of the Moscow Region].
    Baturin AK; Sorokina EY; Pogozheva AV; Peskova EV; Makurina ON; Tutelyan VA
    Vopr Pitan; 2015; 84(1):44-9. PubMed ID: 26402942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variance in Uncoupling Protein 2 in Relation to Obesity, Type 2 Diabetes, and Related Metabolic Traits: Focus on the Functional -866G>A Promoter Variant (rs659366).
    Dalgaard LT
    J Obes; 2011; 2011():340241. PubMed ID: 21603268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases.
    Yu X; Wieczorek S; Franke A; Yin H; Pierer M; Sina C; Karlsen TH; Boberg KM; Bergquist A; Kunz M; Witte T; Gross WL; Epplen JT; Alarcón-Riquelme ME; Schreiber S; Ibrahim SM
    Genes Immun; 2009 Sep; 10(6):601-5. PubMed ID: 19387457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of UCP2 -866G>A Polymorphism With Nonalcoholic Fatty Liver Disease in Patients From North-West of Iran.
    Mohseni F; Farajnia S; Farhangi MA; Khoshbaten M; Jafarabadi MA
    Lab Med; 2017 Feb; 48(1):65-72. PubMed ID: 27794526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.
    Krempler F; Esterbauer H; Weitgasser R; Ebenbichler C; Patsch JR; Miller K; Xie M; Linnemayr V; Oberkofler H; Patsch W
    Diabetes; 2002 Nov; 51(11):3331-5. PubMed ID: 12401727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An association between -866G/A polymorphism in the promoter of UCP2 and obesity: a meta-analysis.
    Liu L; Zhao X; Kang S; Zhang D
    Gene; 2013 Feb; 514(1):41-7. PubMed ID: 23147265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the UCP2 core promoter and relationships of variants with obesity.
    Dalgaard LT; Andersen G; Larsen LH; Sørensen TI; Andersen T; Drivsholm T; Borch-Johnsen K; Fleckner J; Hansen T; Din N; Pedersen O
    Obes Res; 2003 Nov; 11(11):1420-7. PubMed ID: 14627764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UCP2 A55V variant is associated with obesity and related phenotypes in an aboriginal community in Taiwan.
    Wang TN; Huang MC; Lin HL; Hsiang CH; Ko AM; Chang WT; Ko YC
    Int J Obes (Lond); 2007 Nov; 31(11):1746-52. PubMed ID: 17502873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.